Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

On March 12, 2014, Recro Pharma, Inc (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) stock performance was -4.64% in last session and finished the day at $6.98. Traded volume was 43.6K shares in the last session and the … Continue reading Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Stocks Touched New Lows: Zoetis Inc (NYSE:ZTS), Coldwater Creek Inc. (NASDAQ:CWTR), Antares Pharma Inc (NASDAQ:ATRS), Outdoor Inc (NYSE:CBSO)

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (EDT) on Tuesday, May 6, 2014. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Rick Passov will review first quarter 2014 financial results and respond to questions from financial analysts during the call. Zoetis Inc (NYSE:ZTS) stock performance was -0.24% in last session and finished the … Continue reading Stocks Touched New Lows: Zoetis Inc (NYSE:ZTS), Coldwater Creek Inc. (NASDAQ:CWTR), Antares Pharma Inc (NASDAQ:ATRS), Outdoor Inc (NYSE:CBSO)

FB Nasdaq FB Facebook

Financial Sector Active Runners: Bank of America Corp (NYSE:BAC), Citigroup Inc (NYSE:C), JPMorgan (NYSE:JPM), Wells Fargo (NYSE:WFC)

Bank of America Corp (NYSE:BAC)‘s stock had its “market perform” rating reiterated by equities research analysts at FBR Capital Markets in a research note issued to investors on Thursday. Bank of America Corp (NYSE:BAC) stock performance was 1.30% in last session and finished the day at $17.20. Traded volume was 62.12million shares in the last session and the average volume of the stock remained 109.80million … Continue reading Financial Sector Active Runners: Bank of America Corp (NYSE:BAC), Citigroup Inc (NYSE:C), JPMorgan (NYSE:JPM), Wells Fargo (NYSE:WFC)

Aon’s Q1 Growth Weaker Than Expected

Aon’s first-quarter results showed weaker-than-expected growth in HR Consulting. Overall, the company reported 2% growth in revenue and essentially no change in operating margins at 18.5%. The company reported adjusted operating income–net of restructuring charges and amortization of intangible assets–of $538 million, up about 2% from a year ago. Revenue growth slowed significantly within the consulting segment. The unit reported a 1% year-over-year increase due … Continue reading Aon’s Q1 Growth Weaker Than Expected

MeadWestvaco Joint Ventures Highlight Q3 Earnings Report

After reviewing MeadWestvaco’s third-quarter results and the pending land sale with Plum Creek Timber, analysts do not expect to materially change the fair value estimate of $34 per share. Starting with third-quarter results, solid performance from MWV’s Industrial and Specialty Chemicals divisions again offset persistent weakness in the Food and Beverage and the Home, Health, and Beauty segments–a trend we expect to continue going into … Continue reading MeadWestvaco Joint Ventures Highlight Q3 Earnings Report

Pengrowth Energy Struggles in the Second Quarter

Pengrowth Energy reported earnings after the market close Wednesday. Earnings and cash flow fell, and uncertainty over the sustainability of the dividend persisted. The firm is once again in the position of requiring additional divestitures or making a dividend cut within the upcoming year. The problem for Pengrowth is that the continued payment of the dividend, combined with net losses, is eating into its book … Continue reading Pengrowth Energy Struggles in the Second Quarter